Advertisement
Contributing writer
Bianca G. Ciubancan
Latest Content
Harvard’s Wyss Institute Gives Startup License to Use Newly-Developed Biomaterials
Attivare Therapeutics, a startup founded by researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering, received a license from the Wyss Institute to use biomaterials developed at Harvard to create treatments for tumors that do not respond to existing immunotherapies.
Advertisement